{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:24Z","timestamp":1786993704788,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lanepe.2026.101712","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:50:44Z","timestamp":1779753044000},"page":"101712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-662X","authenticated-orcid":false,"given":"Camila A.","family":"Picchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Nicol\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Duffell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Martr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dudareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Vanderlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upkar S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-1053","authenticated-orcid":false,"given":"Devin","family":"Razavi-Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Halford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanwolleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2026.101712_bib1","series-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis","year":"2016"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101712_bib3","article-title":"Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: a public health approach for effective preventive hepatology","volume":"7","author":"Ivancovsky Wajcman","year":"2025","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101712_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S2468-1253(21)00182-5","article-title":"Hepatitis C in Iceland: a milestone for global elimination","volume":"6","author":"Dalgard","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101712_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","article-title":"A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/idr12030016","article-title":"Trends of late presentation to care in patients with chronic hepatitis C during a 10-year period in Croatia","volume":"12","author":"Papic","year":"2020","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.lanepe.2026.101712_bib11","series-title":"Hepatitis B: Annual epidemiological report for 2023","year":"2023"},{"key":"10.1016\/j.lanepe.2026.101712_bib13","series-title":"Europe's beating cancer plan: a new EU approach to prevention, treatment and care","year":"2021"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib14","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s44197-023-00109-0","article-title":"Global, regional, and national trends in incidence and mortality of primary liver cancer and its underlying etiologies from 1990 to 2019: results from the Global Burden of Disease study 2019","volume":"13","author":"Cao","year":"2023","journal-title":"J Epidemiol Glob Health"},{"issue":"30","key":"10.1016\/j.lanepe.2026.101712_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200738","article-title":"Estimates of hepatitis B virus prevalence among general population and key risk groups in EU\/EEA\/UK countries: a systematic review","volume":"28","author":"Bivegete","year":"2023","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jhep.2017.10.010","article-title":"Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe","volume":"68","author":"Fraser","year":"2018","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101712_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101712_bib21","series-title":"Hepatitis B \u2013 [Country name]","year":"2025"},{"key":"10.1016\/j.lanepe.2026.101712_bib41","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"10.1016\/j.lanepe.2026.101712_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1118227","article-title":"A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU\/EEA region","volume":"11","author":"Moonen","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.lanepe.2026.101712_bib24","article-title":"Estimating the impact of displacement from Ukraine on HBV and HCV prevalence among migrants in the European Union, 2024: a modeling study","volume":"58","author":"Razavi-Shearer","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"e59","key":"10.1016\/j.lanepe.2026.101712_bib25","article-title":"Hepatitis B virus infection in EU\/EEA and United Kingdom prisons: a descriptive analysis","volume":"149","author":"Nakitanda","year":"2021","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.lanepe.2026.101712_bib26","author":"Seyler"},{"key":"10.1016\/j.lanepe.2026.101712_bib27","author":"Jes\u00fas"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib28","first-page":"373","article-title":"HCV testing and linkage to care for hepatitis C virus infection for marginalized drug user populations attending a harm reduction service in Bologna, Italy","volume":"32","author":"Pavarin","year":"2024","journal-title":"Infez Med"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13011-023-00527-0","article-title":"Linkage to hepatitis C treatment in two opioid substitution treatment units in Gothenburg, Sweden: a retrospective cohort study","volume":"18","author":"Ydreborg","year":"2023","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2471\/BLT.20.260919","article-title":"Improving care of migrants is key for viral hepatitis elimination in Europe","volume":"99","author":"Kim","year":"2021","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanepe.2026.101712_bib32","series-title":"A pilot survey of stigma related to infection with hepatitis B and C","year":"2025"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S2468-1253(23)00321-7","article-title":"Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update","volume":"9","author":"Cooke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101712_bib35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S2468-1253(25)00163-3","article-title":"Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis","volume":"10","author":"Stockdale","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101712_bib36","series-title":"Hepatitis B vaccination policies, practices and challenges to achieving hepatitis elimination in the European Union and European Economic Area","year":"2025"},{"key":"10.1016\/j.lanepe.2026.101712_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81070","article-title":"The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda","volume":"12","author":"Martyn","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12954-024-01115-6","article-title":"How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023","volume":"21","author":"Maticic","year":"2024","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.lanepe.2026.101712_bib40","series-title":"Global hepatitis report, 2017","year":"2017"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2055-6640(20)30036-4","article-title":"Modelling the impact of different testing strategies for HCV infection in Switzerland","volume":"5","author":"Sadeghimehr","year":"2019","journal-title":"J Virus Erad"},{"key":"10.1016\/j.lanepe.2026.101712_bib43","article-title":"Prevalence of chronic HCV infection in EU\/EEA countries in 2019 using multiparameter evidence synthesis","volume":"36","author":"Thomadakis","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2026.101712_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1567033","article-title":"Health and economic impact of hepatitis B vaccination in the national immunization program in Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Turkmenistan and Uzbekistan-a modelling study","volume":"13","author":"Sadeghimehr","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.lanepe.2026.101712_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijregi.2023.11.003","article-title":"Evaluating the hepatitis B vaccination impact in the Republic of Moldova: a nationwide representative serosurvey of children born in 2013","volume":"10","author":"Brandl","year":"2024","journal-title":"IJID Reg"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12879-025-10491-8","article-title":"Nationwide representative serosurvey of third-grade school children to evaluate the hepatitis B vaccination impact in Kyrgyzstan, 2022","volume":"25","author":"Brandl","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/joim.12972","article-title":"We know DAA s work, so now what? Simplifying models of care to enhance the hepatitis C cascade","volume":"286","author":"Lazarus","year":"2019","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib48","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s10903-021-01305-5","article-title":"Fitting health care to people: understanding and adapting to the epidemiology and health literacy of people affected by viral hepatitis from culturally and linguistically diverse migrant backgrounds","volume":"24","author":"Taye","year":"2022","journal-title":"Immigr Minor Health"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004275","article-title":"The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection","volume":"6","author":"Pley","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"45","key":"10.1016\/j.lanepe.2026.101712_bib50","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400100","article-title":"Self-reported hepatitis A and B vaccination coverage among men who have sex with men (MSM), associated factors and vaccination recommendations in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017","volume":"29","author":"Brandl","year":"2024","journal-title":"Euro Surveill"},{"issue":"48","key":"10.1016\/j.lanepe.2026.101712_bib51","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1016\/j.vaccine.2014.09.042","article-title":"Hepatitis B: are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries","volume":"32","author":"Levi","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2020.06.008","article-title":"Strengthening vaccine confidence during the COVID-19 pandemic: a new opportunity for global hepatitis B virus elimination","volume":"73","author":"Lazarus","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101712_bib53","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/ijerph15091898","article-title":"The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU\/EEA: a systematic review","volume":"15","author":"Myran","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s43856-023-00420-8","article-title":"Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain","volume":"3","author":"Picchio","year":"2023","journal-title":"Commun Med"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101712_bib55","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/children10101681","article-title":"Mobile vaccination teams for improving vaccination coverage in the Kyrgyz Republic: results of a national health system-strengthening project during the first two years of the COVID-19 pandemic","volume":"10","author":"Monolbaev","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.lanepe.2026.101712_bib56","article-title":"Navigating healthcare pathways: cascade of prevention and care for chronic viral hepatitis in asylum seekers and refugees. A multicenter analysis in Northern Italy","volume":"11","author":"Formenti","year":"2025","journal-title":"J Migr Health"},{"issue":"30","key":"10.1016\/j.lanepe.2026.101712_bib57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.15585\/mmwr.mm7330a1","article-title":"Progress toward the elimination of hepatitis B and hepatitis C in the country of Georgia, April 2015-April 2024","volume":"73","author":"Tohme","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanepe.2026.101712_bib58","series-title":"Hepatitis C Action Plan for Scotland - phase I: september 2006 - august 2008","year":"2006"},{"key":"10.1016\/j.lanepe.2026.101712_bib59","series-title":"Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection","year":"2022"},{"key":"10.1016\/j.lanepe.2026.101712_bib60","series-title":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","year":"2024"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2468-1253(22)00346-6","article-title":"Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis","volume":"8","author":"Trickey","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2026.101712_bib62","series-title":"Self-testing implementation toolkit for HIV, hepatitis and sexually transmitted infections","year":"2025"},{"key":"10.1016\/j.lanepe.2026.101712_bib63","series-title":"Toolkit |peer involvement \u2013 European harm reduction network","year":"2011"},{"key":"10.1016\/j.lanepe.2026.101712_bib64","series-title":"Key components of Point-of-Care Testing Programs: a Summary report from the 2025 INHSU Hepatitis C Point-of-Care testing forum","year":"2025"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanepe.2026.101712_bib68","series-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","year":"2018"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101712_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5694\/mja2.51204","article-title":"Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program","volume":"215","author":"Stafford","year":"2021","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-Effectiveness of 1-Time universal screening for chronic hepatitis B infection in adults in the United States","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/liv.15216","article-title":"Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination","volume":"42","author":"D'Ambrosio","year":"2022","journal-title":"Liver Int"},{"issue":"103917","key":"10.1016\/j.lanepe.2026.101712_bib73","article-title":"Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: a systematic review and meta-analysis","volume":"111","author":"Cunningham","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"103320","key":"10.1016\/j.lanepe.2026.101712_bib74","article-title":"Conceptualising hepatitis C stigma: a thematic synthesis of qualitative research","volume":"96","author":"Harris","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101712_bib76","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/23744235.2020.1784456","article-title":"Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden","volume":"52","author":"Millbourn","year":"2020","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101712_bib78","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S2468-1253(21)00137-0","article-title":"Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study","volume":"6","author":"Olafsson","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101712_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1724","article-title":"Chronic hepatitis C elimination prison initiative: HCV-intensive test and treat, a whole prisoner population HCV test-and-treat program in England","volume":"6","author":"Halford","year":"2023","journal-title":"Health Sci Rep"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101712_bib80","article-title":"Implementing a new HCV model of care for people who use drugs","volume":"6","author":"Herranz Mochales","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.lanepe.2026.101712_bib81","series-title":"\u201cThe collection, testing and use of blood and blood components in Europe\u201d, 2016 report, now available for download from the EDQM","year":"2021"},{"key":"10.1016\/j.lanepe.2026.101712_bib82","series-title":"Migration and asylum in Europe \u2013 2024 edition","year":"2024"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib83","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/apt.16728","article-title":"Real-world outcomes of rapid regional hepatitis C virus treatment scale-up among people who inject drugs in Tayside, Scotland","volume":"55","author":"Byrne","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib84","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jvh.13207","article-title":"The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effective","volume":"27","author":"Buchanan","year":"2020","journal-title":"J Viral Hepat"},{"issue":"104185","key":"10.1016\/j.lanepe.2026.101712_bib85","article-title":"Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark","volume":"121","author":"Demant","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib86","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/diagnostics11050877","article-title":"Hepatitis C micro-elimination beyond prison walls: Navigator-assisted test-and-treat strategy for subjects serving non-custodial sentences","volume":"11","author":"Cabezas","year":"2021","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101712_bib87","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment eradication of hepatitis C: a novel treatment paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanepe.2026.101712_bib88","series-title":"Making Hepatitis C micro-elimination part of day-to-day life in United Kingdom's largest prison","author":"Hurry","year":"2025"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4321\/S1575-06202019000100006","article-title":"Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?","volume":"21","author":"Marco","year":"2019","journal-title":"Rev Esp Sanid Penit"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib90","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1186\/s12889-020-09515-6","article-title":"Hepatitis C virus infection in EU\/EEA and United Kingdom prisons: opportunities and challenges for action","volume":"20","author":"Nakitanda","year":"2020","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14737159.2023.2292645","article-title":"We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?","volume":"24","author":"Grebely","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101712_bib92","article-title":"Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D","volume":"4","author":"Palom","year":"2022","journal-title":"JHEP Rep"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101712_bib93","article-title":"Successful hepatitis B and C screening in the health check-up in the German primary care setting","volume":"6","author":"B\u00e4tz","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.37201\/req\/030.2020","article-title":"Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence","volume":"33","author":"Ledesma","year":"2020","journal-title":"Rev Esp Quimioter"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib95","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/liv.15516","article-title":"Confirmation of guideline-defined hepatitis C screening strategies within the \u201cCheck-Up35+\u201d examination in the primary care setting","volume":"43","author":"Petroff","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib96","article-title":"Integrating viral hepatitis management into the emergency department: a further step towards viral hepatitis elimination","volume":"6","author":"Llaneras","year":"2024","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12245-023-00570-5","article-title":"Emergency department contribution to HCV elimination in the Iberian Peninsula","volume":"17","author":"Buti","year":"2024","journal-title":"Int J Emerg Med"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib98","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/v14051096","article-title":"Elimination of hepatitis C in Southern Italy: a model of HCV screening and linkage to care among hospitalized patients at different hospital divisions","volume":"14","author":"Rosato","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12962-022-00388-7","article-title":"Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom","volume":"20","author":"Williams","year":"2022","journal-title":"Cost Eff Resour Alloc"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101712_bib100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0040-1713657","article-title":"Simplification of care for chronic hepatitis C virus infection","volume":"40","author":"Pawlotsky","year":"2020","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101712_bib101","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.lanepe.2026.101712_bib102","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S2468-1253(20)30120-5","article-title":"Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial","volume":"5","author":"Radley","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib103","first-page":"161","article-title":"Hepatitis C screening in community pharmacies-A feasibility and knowledge transfer study: PHARMA-C","volume":"9","author":"Pr\u00e9vost","year":"2024","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"10.1016\/j.lanepe.2026.101712_bib104","article-title":"Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study","volume":"49","author":"Ward","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib118","doi-asserted-by":"crossref","first-page":"100369","DOI":"10.1016\/j.jve.2024.100369","article-title":"Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country","volume":"10","author":"Ho","year":"2024","journal-title":"J Virus Erad"},{"issue":"105876","key":"10.1016\/j.lanepe.2026.101712_bib105","article-title":"Identifying people with chronic hepatitis B virus who are lost to clinical follow up: a retrospective case finding and re-engagement service improvement exercise","volume":"181","author":"Jackson","year":"2025","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101712_bib106","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.5937\/hpimj2303323B","article-title":"Knowledge and attitudes of healthcare professionals employed in tertiary healthcare institutions about hepatitis B and prevention measures","volume":"10","author":"Brnovi\u0107","year":"2023","journal-title":"Hosp Pharm Int Multi J"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1466-7657.2010.00869.x","article-title":"Nursing students' immunisation status and knowledge about viral hepatitis in Turkey: a multi-centre cross-sectional study","volume":"58","author":"Yamazhan","year":"2011","journal-title":"Int Nurs Rev"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101712_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0336257","article-title":"Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: a mixed-methods study using the COM-B Framework","volume":"20","author":"Sperle","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib109","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1186\/s12889-024-18953-5","article-title":"Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population","volume":"24","author":"Mazhnaya","year":"2024","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101712_bib110","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/vaccines11111645","article-title":"Knowledge, attitudes, and practices of European healthcare professionals towards hepatitis A and hepatitis B vaccination in at-risk adults","volume":"11","author":"Shamarina","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101712_bib111","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12879-015-1104-8","article-title":"Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey","volume":"15","author":"Bechini","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.lanepe.2026.101712_bib112","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/v15122454","article-title":"Hepatitis B in healthcare personnel: an update on the global landscape","volume":"15","author":"Nikolopoulou","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gastrohep.2022.09.009","article-title":"Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction","volume":"46","author":"Crespo","year":"2023","journal-title":"Gastroenterol Hepatol"},{"issue":"25","key":"10.1016\/j.lanepe.2026.101712_bib116","first-page":"S0168","article-title":"Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond","volume":"13","author":"Sonneveld","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101712_bib117","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, Progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:19:01Z","timestamp":1780388341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":101,"alternative-id":["S2666776226001249"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101712","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101739","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101713","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101723","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101722","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101731","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101742","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101707","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101712"}}